ATRA

Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1/2
Enrollment
42 patients (estimated)
Sponsors
Houston Methodist Hospital Research Institute, Houston Methodist Hospital Research Institute
Collaborators
Cancer Prevention Research Institute of Texas
Tags
Vitamins
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1975
NCT Identifier
NCT06536413

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.